Page 27 - Summer 2017 Journal

Trends Pharmacol Sci 2002;23(10):482-7.
54. Ridker PM, Lüscher TF. Anti-inflammatory therapies for cardiovascular disease. Eur Heart J 2014;35(27):1782-91.
55. Maeda T, Kawane T, Horiuchi N. Statins augment vascular endothelial growth factor expression in osteoblastic cells via inhibition of protein prenylation. Endocrinology
2003;144(2):681-92.
56. Nakazato R, Gransar H, Berman DS, Cheng VY, Lin FY,
Achenbach S, et al. Statins use and coronary artery plaque composition: results from the International Multicenter CONFIRM Registry. Atherosclerosis 2012;225(1):148-53.
57. Horwich TB, Hamilton MA, MacLellan WR, Fonarow GC. Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure. J Card Fail 2002;8(4):216-24.
58. Rauchhaus M, Clark AL, Doehner W, Davos C, Bolger A, Sharma R, et al. The relationship between cholesterol and survival in patients with chronic heart failure. J Am Coll Cardiol 2003;42(11):1933-40.
59. Fonarow GC, Horwich TB. Cholesterol and mortality in heart failure: the bad gone good? J Am Coll Cardiol 2003;42(11):1941-1942.
ischemic disorders may reflect a down-regulation of neutrophil activation and adhesion.
Med Hypotheses 1999;53(4):290-9.
74. Paasonen MK, Penttil a O, Himberg JJ, Solatunturi E. Platelet taurine in patients with arte-
rial hypertension, myocardial failure or infarction. Acta Med Scand Suppl 1980;642:79-84. 75. Vogt W. Complement activation by myeloperoxidase products released from stimulated
human polymorphonuclear leukocytes. Immunobiology 1996;195(3):334-46.
76. Schaffer SW, Jong CJ, Ito T, Azuma J. Effect of taurine on ischemia-reperfusion injury.
Amino Acids 2014;46(1):21-30.
77. Yamori Y, Liu L, Ikeda K, Miura A, Mizushima S, Miki T, Nara Y on behalf of the WHO-
Cardiovascular Disease and Alimentary Comparison (CARDIAC) Study Group. Distribution of twenty-four hour urinary taurine excretion and association with ischemic heart disease mortality in 24 populations of 16 countries: results from the WHO-CARDIAC study. Hy- pertens Res 2001;24(4):453-7.
78. Chen Q, Moghaddas S, Hoppel CL, Lesnefsky EJ. Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria. Am J Physiol Cell Physiol 2008;294(2):C460-C466.
79. Chen Q, Paillard M, Gomez L, Li H, Hu Y, Lesnefsky EJ. Postconditioning modulates isch- emia-damaged mitochondria during reperfusion. J Cardiovasc Pharmacol 2012;59(1):101-8. 80. Stipanuk MH, Ueki I. Dealing with methionine/homocysteine sulfur: cysteine metabolism
to taurine and inorganic sulfur. J Inherit Metab Dis 2011;34(1):17-32.
81. McCully KS. Chemical pathology of homocysteine. V. Thioretinamide, thioretinaco, and cystathionine synthase function in degenerative diseases. Ann Clin Lab Sci 2011;41(4):301-
60. Huxtable RJ. Physiological actions of taurine. Physiol Rev 14.
82. Simon JA. Vitamin C and cardiovascular disease: a review. J Am Coll Nutr 1992;11(2):107- 61. Denger K, Laue H, Cook AM. Thiosulfate as a metabolic 125.
1992;72(1):101-163.
product: the bacterial fermentation of taurine. Arch Mi-
crobiol 1997;168(4):297-301.
62. Sturman JA, Hepner GW, Hofmann AF, Thomas PJ. Me-
tabolism of [35S] taurine in man. J Nutr 1975;105(9):1206-
14.
63. Milei J, Ferreira R, Llesuy S, Forcada P, Covarrubias J,
Boveris A. Reduction of reperfusion injury with preopera- tive rapid intravenous infusion of taurine during myocar- dial revascularization. Am Heart J 1992;123(2):339-45.
64. Briet F, Keith M, Leong-Poi H, Kadakia A, Aba-Alkhail K, Giliberto JP, et al. Triple nutrient supplementation im- proves survival, infarct size and cardiac function following myocardial infarction in rats. Nutr Metab Cardiovasc Dis 2008;18(10):691-9.
83. Xu Y-J, Arneja AS, Tappia PS, Dhalla NS. The potential health benefits of taurine in car- diovascular disease. Exp Clin Cardiol 2008;13(2):57-65.
84. Liao X-B, Zhou X-M, Li J-M, Yang J-F, Tan Z-P, Hu Z-W, et al. Taurine inhibits osteo- blastic differentiation of vascular smooth muscle cells via the ERK pathway. Amino Acids 2008;34(4):525-30.
85. Kramer JH, Chovan JP, Schaffer SW. Effect of taurine on calcium paradox and ischemic heart failure. Am J Physiol 1981;240(2):H238-H246.
86. Kingston R, Kelly CJ, Murray P. The therapeutic role of taurine in ischaemia-reperfusion injury. Curr Pharm Des 2004;10(19):2401-10.
87. Olszowski S, Olszowska E, Kusior D, Szneler E. Sulphoacetaldehyde as a product of taurine chloramine peroxidation at site of inflammation. Amino Acids 2002;22(2):145-153.
88. Guo W, Li JY, King H, Locke FB. Diet and blood nutrient correlations with ischemic heart, hypertensive heart, and stroke mortality in China. Asia Pac J Public Health 1992;6(4):200-9. 89. Rahman K, Lowe GM. Garlic and cardiovascular disease: a critical review. J Nutr
2006;136(3):736S-740S.
90. Wollin SD, Jones PJH. α-Lipoic acid and cardiovascular disease. J Nutr 2003;133(11):3327-
65. Torres CL, Walker NJ, Rogers QR, Tablin F. Platelet
taurine concentration can be predicted from whole blood
taurine concentrations in dogs. J Nutr 2006;136(7):2055S- 30.
2057S.
66. Hayes KC, Pronczuk A, Addesa AE, Stephan ZF. Taurine
modulates platelet aggregation in cats and humans. Am J
Clin Nutr 1989;49(6):1211-6.
67. Crass MF 3rd, Song W, Lombardini JB. Cardiac muscle
taurine: effects of acute left ventricular ischemia in the dog and anoxic perfusion of the rat heart. Recent Adv Stud Cardiac Struct Metab 1976;12:259-63.
68. Crass MF III, Lombardini JB. Loss of cardiac muscle taurine after acute left ventricular ischemia. Life Sci 1977;21(7):951-8.
69. Hasegawa T, Malle E, Farhood A, Jaeschke H. Generation of hypochlorite-modified proteins by neutrophils during ischemia-reperfusion injury in rat liver: attenuation by ischemic preconditioning. Am J Physiol Gastrointest Liver Physiol 2005;289:G760-G767.
70. Heslop CL, Frohlich JJ, Hill JS. Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography. J Am Coll Cardiol 2010;55(11):1102-9.
71. Rosen H, Crowley JR, Heinecke JW. Human neutrophils use the myeloperoxidase-hydrogen peroxide-chloride system to chlorinate but not nitrate bacterial proteins during phagocytosis. J Biol Chem 2002;277:30463-8.
72. Ravnskov U, McCully KS. Review and hypothesis: vulnerable plaque formation from obstruction of vasa vasorum by homocysteinylated and oxidized lipoprotein aggregates complexed with microbial remnants and LDL autoantibodies. Ann Clin Lab Sci 2009;39(1):3-16.
73. McCarty MF. The reported clinical utility of taurine in
SUMMER 2017
91. Bilska A, Dudek M, Iciek M, Kwiecień I, Sokołowska-Jezewicz M, Filipek B, et al. Bio- logical actions of lipoic acid associated with sulfane sulfur metabolism. Pharmacol Rep 2008;60(2):225-32.
92. Chou MM, Vergnolle N, McDougall JJ, Wallace JL, Marty S, Teskey V, et al. Effects of chondroitin and glucosamine sulfate in a dietary bar formulation on inflammation, interleukin-1β, matrix metalloprotease-9, and cartilage damage in arthritis. Exp Biol Med (Maywood) 2005;230(4):255-62.
93. Bhuiyan MS, Takada Y, Shioda N, Moriguchi S, Kasahara J, Fukunaga K. Cardioprotec- tive effect of vanadyl sulfate on ischemia/reperfusion-induced injury in rat heart in vivo is mediated by activation of protein kinase B and induction of FLICE-inhibitory protein. Cardiovasc Ther 2008;26(1):10-23.
94. Sochman J. N-acetylcysteine in acute cardiology: 10 years later: what do we know and what would we like to know?! J Am Coll Cardiol 2002;39(9):1422-8.
95. Woods KL, Fletcherk S, Roffe C, Haider Y. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Inter- vention Trial (LIMIT-2). Lancet 1992;339(8809):1553-8.
96. Del Giudice E, Tedeschi A, Vitiello G, Voeikov V. Coherent structures in liquid water close to hydrophilic surfaces. J Phys Conf Ser 2013;442(1):012028.
97. Pollack G. Cells, Gels and the Engines of Life: A New, Unifying Approach to Cell Function. Seattle, WA: Ebner and Sons, 2001.
98. Pollack G. The Fourth Phase of Water: Beyond Solid, Liquid, and Vapor. Seattle, WA: Ebner and Sons, 2013.
99. Trivedi DP, Hallock KJ, Bergethon PR. Electric fields caused by blood flow modulate vascular endothelial electrophysiology and nitric oxide production. Bioelectromagnetics 2013;34(1):22-30.
Wise Traditions 27